Third-Generation Trabecular Micro-Bypass Implantation and Phacoemulsification in Patients with Glaucoma: A Multicenter Study [PDF]
This multicenter study evaluated the effectiveness and safety of third-generation trabecular micro-bypass implantation (iStent® infinite) combined with phacoemulsification (n = 233 eyes).
Mitchell Shultz +4 more
doaj +7 more sources
Third-Generation Trabecular Micro-Bypass Implantation with Phacoemulsification for Glaucoma [PDF]
Introduction This retrospective, consecutive, real-world case series assessed the efficacy and safety of third-generation trabecular micro-bypass stent implantation (iStent infinite) with phacoemulsification in patients with mild-to-moderate primary open-
Zachary Vest +2 more
doaj +5 more sources
iStent Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in a Japanese Glaucoma Population [PDF]
Koji Nitta,1 Yutaro Yamada,1 Satomi Morokado,1 Kazuhisa Sugiyama2 1Department of Ophthalmology, Fukui-Ken Saiseikai Hospital, Fukui, Fukui Prefecture, Japan; 2Department of Ophthalmology, Kanazawa University, Kanazawa, Ishikawa Prefecture ...
Nitta K +3 more
doaj +7 more sources
Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery [PDF]
Ricardo Augusto Paletta Guedes,1 Daniela Marcelo Gravina,1 Vanessa Maria Paletta Guedes,1 Alfredo Chaoubah2 1Glaucoma Department, Paletta Guedes Eye Institute, Juiz de Fora, MG, Brazil; 2Statistics Department, Federal University of Juiz De Fora, Juiz de ...
Paletta Guedes RA +3 more
doaj +7 more sources
Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma [PDF]
Mark J Gallardo,1,2 Richard A Supnet11El Paso Eye Surgeons, PA, El Paso, TX, USA; 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USAPurpose: To present long-term, real-world outcomes after ...
Gallardo MJ, Supnet RA
doaj +5 more sources
Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population [PDF]
Ahmed Al Habash,1 Omar Khan2 1Department of Ophthalmology, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Ministry of Health, Madinah, Saudi ArabiaCorrespondence: Ahmed Al Habash ...
Al Habash A, Khan O
doaj +4 more sources
Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication [PDF]
Richard Lindstrom, 1 Steven R Sarkisian, 2 Richard Lewis, 3 John Hovanesian, 4 Lilit Voskanyan 5 1Minnesota Eye Consultants, Minneapolis, MN, USA; 2Oklahoma Eye Surgeons, PLLC, Oklahoma City, OK, USA; 3Sacramento Eye Consultants, Sacramento, CA, USA;
Lindstrom R +4 more
doaj +4 more sources
Efficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma [PDF]
Introduction This study evaluated efficacy and safety of implanting two second-generation trabecular micro-bypass stents (iStent inject/iStent inject W) with phacoemulsification, either with or without iAccess Precision Blade goniotomy, in patients with ...
Mark J. Gallardo, Matthew Porter
doaj +2 more sources
Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study [PDF]
Purpose The efficacy and safety of the trabecular micro-bypass stents (iStent and iStent inject) have been well documented in various open-angle glaucoma subtypes. However, their outcomes remain understudied in normal-tension glaucoma (NTG).
Ali Salimi +3 more
doaj +2 more sources
Ten-Year Effectiveness and Safety of Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Patients with Glaucoma or Ocular Hypertension [PDF]
Introduction This study evaluated 10-year results of implanting one iStent trabecular micro-bypass stent during cataract surgery in eyes with open-angle glaucoma (OAG) or ocular hypertension.
Tobias H. Neuhann +2 more
doaj +2 more sources

